ATXS
Price
$11.50
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
50 days until earnings call
IMNM
Price
$15.40
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
54 days until earnings call
Ad is loading...

ATXS vs IMNM

Header iconATXS vs IMNM Comparison
Open Charts ATXS vs IMNMBanner chart's image
Astria Therapeutics
Price$11.50
Change-$0.00 (-0.00%)
Volume$255.78K
CapitalizationN/A
Immunome
Price$15.40
Change-$0.00 (-0.00%)
Volume$1.3M
CapitalizationN/A
View a ticker or compare two or three
ATXS vs IMNM Comparison Chart
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ATXS vs. IMNM commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Buy and IMNM is a Buy.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (ATXS: $11.50 vs. IMNM: $15.40)
Brand notoriety: ATXS and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 86% vs. IMNM: 233%
Market capitalization -- ATXS: $648.89M vs. IMNM: $948.26M
ATXS [@Biotechnology] is valued at $648.89M. IMNM’s [@Biotechnology] market capitalization is $948.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $609.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATXS and IMNM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 5 TA indicator(s) are bullish while IMNM’s TA Score has 7 bullish TA indicator(s).

  • ATXS’s TA Score: 5 bullish, 3 bearish.
  • IMNM’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than ATXS.

Price Growth

ATXS (@Biotechnology) experienced а +1.50% price change this week, while IMNM (@Biotechnology) price change was +5.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.17%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was -2.02%.

Reported Earning Dates

ATXS is expected to report earnings on Nov 07, 2024.

IMNM is expected to report earnings on Nov 11, 2024.

Industries' Descriptions

@Biotechnology (+1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($948M) has a higher market cap than ATXS($649M). ATXS YTD gains are higher at: 49.740 vs. IMNM (43.925). IMNM has higher annual earnings (EBITDA): -71.17M vs. ATXS (-92.19M). ATXS has more cash in the bank: 355M vs. IMNM (278M). IMNM has less debt than ATXS: IMNM (2.77M) vs ATXS (5.79M). IMNM has higher revenues than ATXS: IMNM (10.8M) vs ATXS (0).
ATXSIMNMATXS / IMNM
Capitalization649M948M68%
EBITDA-92.19M-71.17M130%
Gain YTD49.74043.925113%
P/E RatioN/AN/A-
Revenue010.8M-
Total Cash355M278M128%
Total Debt5.79M2.77M209%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSIMNM
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WWWFX79.451.88
+2.42%
Kinetics Internet No Load
GFSIX15.260.11
+0.73%
Gabelli Global Financial Services I
SMFCX26.500.02
+0.08%
American Beacon Stephens Mid-Cap Gr C
TRTIX18.17-0.06
-0.33%
T. Rowe Price International Value Eq I
VMVFX16.22-0.08
-0.49%
Vanguard Global Minimum Volatility Inv

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with KALV. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then KALV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
+2.40%
KALV - ATXS
41%
Loosely correlated
-1.86%
ADCT - ATXS
39%
Loosely correlated
+1.30%
INZY - ATXS
38%
Loosely correlated
-2.67%
RCKT - ATXS
38%
Loosely correlated
+13.54%
SNDX - ATXS
37%
Loosely correlated
-0.77%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with TNYA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then TNYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-2.47%
TNYA - IMNM
40%
Loosely correlated
+4.02%
XNCR - IMNM
39%
Loosely correlated
-0.52%
KOD - IMNM
37%
Loosely correlated
N/A
DNTH - IMNM
36%
Loosely correlated
-1.63%
ATXS - IMNM
36%
Loosely correlated
+2.40%
More